IRF8 Recombinant Rabbit Monoclonal Antibody [PSH10-05]
Catalog# HA723174
IRF8 Recombinant Rabbit Monoclonal Antibody [PSH10-05]
-
WB
-
IF-Cell
-
FC
-
IP
-
Human
-
Mouse
-
HA751335
不含抗保成分
-
unconjugated
Overview
Product Name
IRF8 Recombinant Rabbit Monoclonal Antibody [PSH10-05]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Recombinant protein within human IRF8 aa 81-426.
Species Reactivity
Human, Mouse
Validated Applications
WB, IF-Cell, FC, IP
Molecular Weight
Predicted band size: 48 kDa
Positive Control
Raji cell lysate, Ramos cell lysate, THP-1 cell lysate, A20 cell lysate, A20, THP-1.
Conjugation
unconjugated
Clone Number
PSH10-05
Reactivity Data
| WB | IF-Cell | FC | IP | |
|---|---|---|---|---|
| Human |
|
|
|
|
| Mouse |
|
|
||
| Rat |
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
PBS (pH7.4), 0.1% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:2,000
-
IF-Cell
-
1:100
-
FC
-
1:1,000
-
IP
-
1-2μg/sample
Target
Function
Interferon regulatory factor 8 (IRF8) also known as interferon consensus sequence-binding protein (ICSBP), is a protein that in humans is encoded by the IRF8 gene. IRF8 is a transcription factor that plays critical roles in the regulation of lineage commitment and in myeloid cell maturation including the decision for a common myeloid progenitor (CMP) to differentiate into a monocyte precursor cell. Interferon Consensus Sequence-binding protein (ICSBP) is a transcription factor of the interferon regulatory factor (IRF) family. Proteins of this family are composed of a conserved DNA-binding domain in the N-terminal region and a divergent C-terminal region that serves as the regulatory domain. The IRF family proteins bind to the IFN-stimulated response element (ISRE) and regulate expression of genes stimulated by type I IFNs, namely IFN-α and IFN-β. IRF family proteins also control expression of IFN-α and IFN-β-regulated genes that are induced by viral infection.
Background References
1. Nixon BG et al. Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer. Immunity. 2022 Nov
2. Moorman HR et al. IRF8: Mechanism of Action and Health Implications. Cells. 2022 Aug
Subcellular Location
Nucleus, Cytoplasm.
Synonyms
H ICSBP antibody
H-ICSBP antibody
HGNC:5358 antibody
HICSBP antibody
ICSBP 1 antibody
ICSBP antibody
ICSBP1 antibody
Interferon consensus sequence binding protein 1 antibody
Interferon consensus sequence binding protein antibody
Interferon consensus sequence-binding protein antibody
ExpandImages
-
☑ Relative expression (RE)
Western blot analysis of IRF8 on different lysates with Rabbit anti-IRF8 antibody (HA723174) at 1/2,000 dilution.
Lane 1: HCT 116 cell lysate (negative)
Lane 2: Raji cell lysate
Lane 3: Ramos cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 48 kDa
Observed band size: 50 kDa
Exposure time: 28 seconds; ECL: K1802;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723174) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of IRF8 on different lysates with Rabbit anti-IRF8 antibody (HA723174) at 1/2,000 dilution.
Lane 1: THP-1 cell lysate
Lane 2: A20 cell lysate
Lysates/proteins at 20 µg/Lane.
Predicted band size: 48 kDa
Observed band size: 50 kDa
Exposure time: 3 minutes; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA723174) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
Immunocytochemistry analysis of A20 cells labeling IRF8 with Rabbit anti-IRF8 antibody (HA723174) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 15 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 15 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-IRF8 antibody (HA723174) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (HA601187, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
☑ Relative expression (RE)
Flow cytometric analysis of HCT 116 (left, negative) and THP-1 (right, positive) cells labeling IRF8.
Cells were fixed and permeabilized. Then stained with the primary antibody (HA723174, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black). -
IRF8 was immunoprecipitated from 0.2 mg THP-1 cell lysate with HA723174 at 2 µg/10 µl beads. Western blot was performed from the immunoprecipitate using HA723174 at 1/1,000 dilution. Mouse Anti-Rabbit IgG kappa light chain secondary antibody (M1208-2) at 1/5,000 dilution was used for 1 hour at room temperature.
Lane 1: THP-1 cell lysate (input)
Lane 2: HA723174 IP in THP-1 cell lysate
Lane 3: Rabbit IgG instead of HA723174 in THP-1 cell lysate
Blocking/Dilution buffer: 5% NFDM/TBST
Exposure time: 59 seconds; ECL: K1801
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"